6
8
Helv. Chim. Acta 2016, 99, 63 – 69
C(8,9,10); HÀC(2’)/C(1’,3’,4’); HÀC(3’)/C(1’,2’,5’); HÀC(4’)/C(2’,3’,6’);
HÀC(5’)/C(3’,4’,7’); HÀC(6’)/C(4’,7’,8’); HÀC(7’)/C(5’,6’,8’); Me(1’’)/
pine-10,2’-oxiran]-4-yl]oxy}-8-oxoocta-2,4,6-trienoic Acid; 7). Color-
less oil. [a]2
5
¼ À29.0 (c ¼ 0.10, CHCl ).
D
3
C(8’). Key NOESY correlations (500 MHz, CDCl ): HÀC(2)/
Hydrolysis of 7. To a soln. (2.0 ml) of 7 (6.0 mg, 15 mmol) in
CH Cl /MeOH 9 :1, MeONa (3.3 mg, 60 mmol) was added, and the
3
H ÀC(13); H ÀC(3)/HÀC(11); HÀC(4)/HÀC(11), Me(15); HÀC(11)/
a
a
2
2
Me(15); H ÀC(13)/H ÀC(7,8), Me(14). HR-ESI-MS: 415.2115 ([M þ
mixture was stirred for 1 h. The solvents were removed in vacuo, the
residue was extracted repeatedly with CH Cl (4 Â 1.0 ml), and the org.
b
b
þ
þ
6
H] , C H O ; calc. 415.2115).
24
31
2
2
Trichodermate C (¼(2E,4Z,6E)-8-{[(2R,4R,5S,5aR,9aR)-2,3,4,5,
a,6,7,9a-Octahydro-10-hydroxy-10-(hydroxymethyl)-5,5a,8-trimethyl-
,5-methano-1-benzoxepin-4-yl]oxy}-8-oxoocta-2,4,6-trienoic Acid; 3).
solvent was evaporated to dryness in vacuo. The product was purified
À1
5
2
by semi-prep. RP-HPLC (MeOH/H O 45: 55 over 45 min; 2 ml min
;
2
detected at 195 nm [16]) to afford 8 (t 31.0 min; 2.6 mg). Colorless
R
25
25
1
Colorless oil. [a]D ¼ À3.6 (c ¼ 0.14, MeOH). UV (MeOH): 302 (4.32).
powder. [a]D ¼ À12.0 (c ¼ 0.16, MeOH). H-NMR (500 MHz, CDCl ):
3
1
13
IR (neat): 3675 (br.), 2981, 1685, 1032. H- and C-NMR: see Table 1.
5.39 (d, J ¼ 5.5, HÀC(10)); 4.33 (dd, J ¼ 7.5, 2.9, HÀC(4)); 3.82 (d, J ¼
HMB Correlations (500 MHz, (D )acetone): HÀC(2)/C(3,12,13);
5.4, HÀC(2)); 3.51 (d, J ¼ 5.5, HÀC(11)); 3.10 (d, J ¼ 3.9, H ÀC(13));
6
a
CH (3)/C(2,4,5,12); HÀC(4)/C(1’,3,5,6,14); CH (7)/C(6,8,9,11,15);
2.81 (d, J ¼ 3.9, H ÀC(13)); 2.61 (dd, J ¼ 15.7, 7.5, H ÀC(3)); 1.99 – 1.97
2
2
b
a
CH (8)/C(6,7,9,10); HÀC(10)/C(6,8,11,16); HÀC(11)/C(2,6,7,9,10,15);
(m, H ÀC(3), CH (8)); 1.92 – 1.90 (m, H ÀC(7)); 1.70 (s, Me(16));
2
b
2
a
CH (13)/C(2,5,12); Me(14)/C(4,5,6,12); Me(15)/C(5,6,7,11); Me(16)/
1.46 – 1.42 (m, H ÀC(7)); 0.85 (s, Me(15)); 0.80 (s, Me(14)).
2
b
C(8,9,10); HÀC(2’)/C(1’,3’,4’); HÀC(3’)/C(1’,2’,5’); HÀC(4’)/C(2’,3’,6’);
HÀC(5’)/C(3’,4’,7’); HÀC(6’)/C(4’,7’,8’); HÀC(7’)/C(5’,6’,8’). Key NO-
ESY correlations (500 MHz, (D )acetone): HÀC(2)/H ÀC(13);
Preparation of (R)- and (S)-MTPA Esters (¼ 8r and 8s). A sample
of
8 (1.1 mg, 4.4 mmol), (S)-MTPACl (5.0 ml, 26 mmol), and
(D )pyridine (0.5 ml) were quickly added to a clean NMR tube at
6
a
5
HÀC(4)/HÀC(11), Me(15); HÀC(11)/Me(15); H ÀC(13)/Me(14).
ambient temp., and all compounds were mixed thoroughly by shaking
b
þ
þ
1
HR-ESI-MS: 419.2064 ([M þ H] , C H O
7
; calc. 419.2064).
the NMR tube carefully. The H-NMR spectrum of the (R)-MTPA
23
31
Trichodermate D (¼ 8-Methyl 1-[(2R,4R,5S,5aR,9aR)-2,3,4,5,
tbcrules=bot5a,6,7,9a-Octahydro-5,5a,8-trimethyl-10-methylidene-2,5-
methano-1-benzoxepin-4-yl] (2Z,4E)-Octa-2,4-dienedioate; 4). Color-
ester derivative was recorded directly every 4 h, and the reaction was
1
found to be complete after 12 h. H-NMR (500 MHz, (D )pyridine) for
5
8r: 5.96 (dd, J ¼ 7.7, 3.5, HÀC(4)); 5.52 (d, J ¼ 5.5, HÀC(10)); 3.92 (d,
J ¼ 5.2, HÀC(2)); 3.68 (d, J ¼ 5.5, HÀC(11)); 3.10 (d, J ¼ 4.2,
H ÀC(13)); 2.82 (d, J ¼ 4.2, H ÀC(13)); 2.68 (dd, J ¼ 15.4, 7.7,
less oil. [a]2 ¼ À26.5 (c ¼ 0.16, MeOH). UV (MeOH): 302 (4.26). IR
5
D
1
13
(
neat): 3670 (br.), 2732, 1655, 1037. H- and C-NMR: see Table 2.
a
b
HMB Correlations (500 MHz, CDCl
3
): HÀC(2)/C(4,5,11,13); CH
2
(3)/
H
a
ÀC(3)); 2.08 (ddd, J ¼ 15.4, 5.2, 3.5, H ÀC(3)); 1.93 – 1.91 (m,
b
C(2,5,12); HÀC(4)/C(1’,2,6,12); CH (7)/C(6,8,9,11); CH (8)/
H ÀC(8)); 1.90 – 1.88 (m, H ÀC(8)); 1.85 – 1.83 (m, H ÀC(7)); 1.63 (s,
2
2
a
b
a
C(6,7,9,10); HÀC(10)/C(6,8,11,16); HÀC(11)/C(7,9,10,15); CH (13)/
Me(16)); 1.30 – 1.27 (m, H ÀC(7)); 0.93 (s, Me(15)); 0.91 (s, Me(14)).
2
b
C(2,5,12); Me(14)/C(4,5,6,12); Me(15)/C(5,6,7,11); Me(16)/C(8,9,10);
HÀC(2’)/C(1’,4’); HÀC(3’)/C(1’,5’); HÀC(4’)/C(2’,3’,6’); HÀC(5’)/
C(3’,6’,7’); HÀC(6’)/C(3’,4’,7’,8’); HÀC(7’)/C(5’,6’,8’); Me(1’’)/C(8’).
Key NOESY correlations (500 MHz, CDCl ): HÀC(2)/H ÀC(13);
Similarly, a mixture of 8 (1.1 mg, 4.4 mmol), (R)-MTPACl (5.0 ml,
26 mmol), and (D )pyridine (0.5 ml) was processed as described above
5
1
for 8r to afford 8s. H-NMR (500 MHz, (D )pyridine) for 8s: 5.89 (dd,
5
J ¼ 7.6, 3.3, HÀC(4)); 5.52 (d, J ¼ 5.8, HÀC(10)); 3.96 (d, J ¼ 5.2,
3
a
H ÀC(3)/HÀC(11); HÀC(4)/HÀC(11), Me(15); HÀC(11)/Me(15);
HÀC(2)); 3.68 (d, J ¼ 5.5, HÀC(11)); 3.11 (d, J ¼ 4.2, H ÀC(13)); 2.79
a
a
þ
þ
H ÀC(13)/Me(14). HR-ESI-MS: 401.2325 ([M þ H] , C H O ; calc.
(d, J ¼ 4.2, H ÀC(13)); 2.75 (dd, J ¼ 15.4, 7.7, H ÀC(3)); 2.20 (ddd, J ¼
b
24 33
5
b
a
4
01.2323).
15.4, 5.2, 3.5, H ÀC(3)); 1.93 – 1.91 (m, H ÀC(8)); 1.90 – 1.88 (m,
b
a
Trichodermate E (¼(2E,4Z,6E)-8-{[(2R,4R,5S,5aR,8R,9aR)-Deca-
H ÀC(8)); 1.85 – 1.83 (m, H ÀC(7)); 1.63 (s, Me(16)); 1.30 – 1.27 (m,
b
a
hydro-8-(hydroxymethyl)-5,5a-dimethylspiro[2,5-methano-1-benzoxe-
H ÀC(7)); 0.90 (s, Me(15)); 0.75 (s, Me(14)).
b
pine-10,2’-oxiran]-4-yl]oxy}-8-oxoocta-2,4,6-trienoic Acid; 5). Color-
Absolute Configuration at C(12) of the 12,13-Diol Moiety in 3 [13].
HPLC Grade DMSO was dried (4 molecular sieves). According to
the published procedure, a 1:1.5 mixture of diol 3/(AcO) Mo was
less oil. [a]2 ¼ À27.0 (c ¼ 0.10, MeOH). UV (MeOH): 302 (4.80). IR
5
D
1
13
(
neat): 3687 (br.), 1699, 1081. H- and C-NMR: see Table 2. HMB
4
2
À1
Correlations (500 MHz, CDCl ): HÀC(2)/C(4,5,11,13); CH (3)/
subjected to CD measurements at a concentration of 0.2 mg ml . The
first CD spectrum was recorded immediately after mixing, and its time
evolution was monitored until stationary (ca. 10 min after mixing). The
inherent CD was subtracted. The observed sign of the diagnostic band
at 310 nm in the induced CD spectrum correlated with the absolute
configuration at C(12) in the 12,13-diol moiety.
3
2
C(2,5,12); HÀC(4)/C(1’,2,6,12); CH (7)/C(6,8,9,11,15); CH (8)/
2
2
C(6,7,9,10); HÀC(9)/C(7,8,16); CH (10)/C(6,8,9,11); HÀC(11)/
2
C(7,9,10,15); CH (13)/C(2,5,12); Me(14)/C(4,5,6,12); Me(15)/
2
C(5,6,7,11); CH (16)/C(8,9,10); HÀC(2’)/C(1’,3’,4’); HÀC(3’)/C(1’,5’);
2
HÀC(4’)/C(2’,3’,6’); HÀC(5’)/C(3’,6’,7’); HÀC(6’)/C(4’,7’,8’); HÀC(7’)/
C(5’,6’,8’). Key NOESY correlations (500 MHz, CDCl ): HÀC(2)/
MTS Assay [17]. In a 96-well plate, each well was plated with (2 –
5) · 103 cells (depending on the cell multiplication rate). After cell
attachment overnight, the medium was removed, and each well was
treated with 100 ml of medium containing 0.1% DMSO, or appropriate
concentrations of the test compounds and the positive control cisplatin
(100 mm stock soln. in DMSO and serial dilutions). The plate was
incubated for 48 h at 378 in a humidified 5%-CO2 atmosphere.
Proliferation was assessed by adding 20 ml of MTS (Promega) to each
well in the dark, followed by 90 min incubation at 378. The assay plate
was read at 490 nm using a microplate reader. The assay was run in
triplicate.
3
H ÀC(13); H ÀC(3)/HÀC(11); HÀC(4)/HÀC(11), Me(15); HÀC(11)/
a
a
HÀC(9), Me(15); H ÀC(13)/CH (16); H ÀC(13)/Me(14). HR-ESI-
a
2
b
þ
þ
7
MS: 419.2069 ([M þ H] , C H O , calc. 419.2064).
23
31
Trichodermate F (¼(2E,4E,6Z)-8-{[(2R,4R,5S,5aR,8R,9aR)-Deca-
hydro-8-(hydroxymethyl)-5,5a-dimethylspiro[2,5-methano-1-benzoxe-
pine-10,2’-oxiran]-4-yl]oxy}-8-oxoocta-2,4,6-trienoic Acid; 6). Color-
less oil. [a]2 ¼ À6.3 (c ¼ 0.14, MeOH). UV (MeOH): 302 (4.23). IR
5
D
1
13
(
neat): 3687 (br.), 2889, 1708, 1037. H- and C-NMR: see Table 2.
HMB Correlations (500 MHz, CDCl ): HÀC(2)/C(4,5,11,12); CH (3)/
3
2
C(2,5,12); HÀC(4)/C(1’,2,5,6,12); CH (7)/C(5,6,8,9,15); CH (8)/
2
2
C(6,7,9); HÀC(9)/C(8,10,16); CH (10)/C(6,8,9,11,16); HÀC(11)/
2
C(2,7,9,10,15); CH (13)/C(2,5,12); Me(14)/C(4,5,6,12); Me(15)/
2
C(5,6,7,11); CH (16)/C(8,9,10); HÀC(2’)/C(1’,3’,4’); HÀC(3’)/C(1’,5’);
2
HÀC(4’)/C(2’,3’,6’); HÀC(5’)/C(3’,6’,7’); HÀC(6’)/C(4’,7’,8’); HÀC(7’)/
REFERENCES
C(5’,6’,8’). Key NOESY correlations (500 MHz, CDCl ): HÀC(2)/
3
H ÀC(13); H ÀC(3)/HÀC(11); HÀC(4)/HÀC(11), Me(15); HÀC(11)/
[1] J. W. Bennett, M. Klich, Clin. Microbiol. Rev. 2003, 16, 497.
[2] P. A. Murphy, S. Hendrich, C. Landgren, C. M. Bryant, J. Food Sci.
2006, 71, R51.
[3] K. Konishi, A. Iida, M. Kaneko, K. Tomioka, H. Tokuda, H.
Nishino, Y. Kumeda, Bioorg. Med. Chem. 2003, 11, 2511.
a
a
HÀC(9), Me(15); H ÀC(13)/CH (16); H ÀC(13)/Me(14). HR-ESI-
a
2
b
þ
þ
7
MS: 419.2069 ([M þ H] , C H O ; calc. 419.2064).
23
31
(
À)-Harzianum B (¼(2E,4Z,6E)-8-{[(2R,4R,5S,5aR,9aR)-2,3,4,
5
,5a,6,7,9a-Octahydro-5,5a,8-trimethylspiro[2,5-methano-1-benzoxe-
www.helv.wiley.com
ꢁ 2016 Verlag Helvetica Chimica Acta AG, Zürich